Dimethyl fumarate attenuates bile acid retention and liver fibrosis in a mouse model of cholestasis
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025-05-01 · 328 (5) · G558-G577
DOI: 10.1152/ajpgi.00262.2024 ↗Abstract
Chronic cholestatic cholangiopathies present a therapeutic challenge due to their complex pathophysiology, where the accumulation of bile acids plays a crucial role. In this study, we found that dimethyl fumarate attenuated cholestatic liver damage in a murine model through its significant anti-inflammatory and antifibrotic activity supported by reduced bile acid accumulation in the plasma and liver via their increased fecal excretion.
EUVIMED